Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 392918, 10 pages
http://dx.doi.org/10.1155/2015/392918
Research Article

Kaurenoic Acid Possesses Leishmanicidal Activity by Triggering a NLRP12/IL-1β/cNOS/NO Pathway

1Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, 86057-970 Londrina, PR, Brazil
2Laboratory of Inflammatory Mediators, State University of Western Parana, 85605-010 Francisco Beltrão, PR, Brazil
3Department of Chemistry, Center of Exact Sciences, State University of Londrina, 86057-970 Londrina, PR, Brazil
4Department of Biochemistry, Federal University of Rio de Janeiro, 21941-909 Rio de Janeiro, RJ, Brazil
5Nucleus of Research in Exact and Technological Sciences, University of Franca, 14404-600 Franca, SP, Brazil

Received 9 December 2014; Accepted 24 April 2015

Academic Editor: Nina Ivanovska

Copyright © 2015 Milena Menegazzo Miranda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Kaye and P. Scott, “Leishmaniasis: complexity at the host-pathogen interface,” Nature Reviews Microbiology, vol. 9, no. 8, pp. 604–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. Ministério da Saúde and Secretaria de Vigilância em Saúde, Manual for Surveillance of American Tegumentary Leishmaniasis, Série A Normas e Manuais Técnicos, Ministério da Saúde, Secretaria de Vigilância em Saúde, Editora do Ministério da Saúde, Brasília, Brazil, 2nd edition, 2010.
  3. H. Goto and J. A. L. Lindoso, “Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis,” Expert Review of Anti-Infective Therapy, vol. 8, no. 4, pp. 419–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. E. Silva-López, “Proteases de Leishmania: novos alvos para o desenvolvimento racional de fármacos,” Química Nova, vol. 33, no. 7, pp. 1541–1548, 2010. View at Publisher · View at Google Scholar
  5. L. F. Oliveira, A. O. Schubach, M. M. Martins et al., “Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World,” Acta Tropica, vol. 118, no. 2, pp. 87–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. T. S. Tiuman, A. O. Santos, T. Ueda-Nakamura, B. P. D. Filho, and C. V. Nakamura, “Recent advances in leishmaniasis treatment,” International Journal of Infectious Diseases, vol. 15, no. 8, pp. e525–e532, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. S. da Silva, G. D. S. Thomé, A. H. D. Cataneo et al., “Brazilian propolis antileishmanial and immunomodulatory effects,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 673058, 7 pages, 2013. View at Publisher · View at Google Scholar
  8. T. Baccarin, A. I. Czepula, R. A. Ferreira, and R. M. Lucinda-Silva, “Análise morfoanatômica das partes aéreas de Wedelia paludosa DC. (Acmela brasiliensis, Sphagneticola trilobata), Asteraceae,” Revista Brasileira de Farmacognosia, vol. 19, pp. 612–616, 2009. View at Google Scholar
  9. R. Batista, G. C. Brandão, F. C. Braga, and A. B. Oliveira, “Cytotoxicity of Wedelia paludosa D.C. extracts and constituents,” Brazilian Journal of Pharmacognosy, vol. 19, no. 1, pp. 36–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Batista, E. Chiari, and A. B. de Oliveira, “Trypanosomicidal kaurane diterpenes from Wedelia paludosa,” Planta Medica, vol. 65, no. 3, pp. 283–284, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Batista, J. L. Humberto, E. Chiari, and A. B. de Oliveira, “Synthesis and trypanocidal activity of ent-kaurane glycosides,” Bioorganic and Medicinal Chemistry, vol. 15, no. 1, pp. 381–391, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Wilkens, C. Alarcón, A. Urzúa, and L. Mendoza, “Characterization of the bactericidal activity of the natural diterpene kaurenoic acid,” Planta Medica, vol. 68, no. 5, pp. 452–454, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. S. Mizokami, N. S. Arakawa, S. R. Ambrosio et al., “Kaurenoic acid from Sphagneticola trilobata inhibits inflammatory pain: effect on cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway,” Journal of Natural Products, vol. 75, no. 5, pp. 896–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. R. Tirapelli, S. R. Ambrosio, F. B. da Costa, S. T. Coutinho, D. C. R. de Oliveira, and A. M. de Oliveira, “Analysis of the mechanisms underlying the vasorelaxant action of kaurenoic acid in the isolated rat aorta,” European Journal of Pharmacology, vol. 492, no. 2-3, pp. 233–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. C. R. Tirapelli, S. R. Ambrosio, A. M. de Oliveira, and R. C. Tostes, “Hypotensive action of naturally occurring diterpenes: a therapeutic promise for the treatment of hypertension,” Fitoterapia, vol. 81, no. 7, pp. 690–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Lim, H. A. Jung, J. S. Choi, Y. S. Kim, S. S. Kang, and H. P. Kim, “Anti-inflammatory activity of the constituents of the roots of Aralia continentalis,” Archives of Pharmacal Research, vol. 32, no. 9, pp. 1237–1243, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. J. Choi, E. M. Shin, H. A. Jung, J. S. Choi, and Y. S. Kim, “Inhibitory effects of kaurenoic acid from Aralia continentalis on LPS-induced inflammatory response in RAW264.7 macrophages,” Phytomedicine, vol. 18, no. 8-9, pp. 677–682, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Izumi, T. Ueda-Nakamura, V. F. Veiga, A. C. Pinto, and C. V. Nakamura, “Terpenes from copaifera demonstrated in vitro antiparasitic and synergic activity,” Journal of Medicinal Chemistry, vol. 55, no. 7, pp. 2994–3001, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. O. dos Santos, E. Izumi, T. Ueda-Nakamura, B. P. Dias-Filho, V. F. da Veiga-Júnior, and C. V. Nakamura, “Antileishmanial activity of diterpene acids in copaiba oil,” Memórias do Instituto Oswaldo Cruz, vol. 108, no. 1, pp. 59–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Van Assche, M. Deschacht, R. A. I. Da Luz, L. Maes, and P. Cos, “Leishmania-macrophage interactions: insights into the redox biology,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 337–351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. S. Faria, F. C. G. Reis, and A. P. C. A. Lima, “Toll-like receptors in Leishmania infections: guardians or promoters?” Journal of Parasitology Research, vol. 2012, Article ID 930257, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Handman and D. V. Bullen, “Interaction of Leishmania with the host macrophage,” Trends in Parasitology, vol. 18, no. 8, pp. 332–334, 2002. View at Publisher · View at Google Scholar
  23. D. Sacks and N. Noben-Trauth, “The immunology of susceptibility and resistance to Leishmania major in mice,” Nature Reviews Immunology, vol. 2, no. 11, pp. 845–858, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. J. K. Krishnaswamy, T. Chu, and S. C. Eisenbarth, “Beyond pattern recognition: NOD-like receptors in dendritic cells,” Trends in Immunology, vol. 34, no. 5, pp. 224–233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Takahashi, “NLRP3 inflammasome as a novel player in myocardial infarction,” International Heart Journal, vol. 55, no. 2, pp. 101–105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. D. S. Lima-Junior, D. L. Costa, V. Carregaro et al., “Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania,” Nature Medicine, vol. 19, no. 7, pp. 909–915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. F. B. da Costa, S. Albuquerque, and W. Vichnewski, “Diterpenes and synthetic derivatives from Viguiera aspillioides with trypanomicidal activity,” Planta Medica, vol. 62, no. 6, pp. 557–559, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Repetto, C. Reides, M. L. Gomez Carretero, M. Costa, G. Griemberg, and S. Llesuy, “Oxidative stress in blood of HIV infected patients,” Clinica Chimica Acta, vol. 255, no. 2, pp. 107–117, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. V. J. Victorino, C. Panis, F. C. Campos et al., “Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women,” Age, vol. 35, no. 4, pp. 1411–1421, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Panis, A. C. S. A. Herrera, V. J. Victorino et al., “Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy,” Breast Cancer Research and Treatment, vol. 133, no. 1, pp. 89–97, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Chatterjee, R. Malhotra, F. Varghese et al., “Quantitative immunohistochemical analysis reveals association between sodium iodide symporter and estrogen receptor expression in breast cancer,” PLoS ONE, vol. 8, no. 1, Article ID e54055, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. K.-S. Lee, D.-K. Lee, D. Jeoung et al., “Differential effects of substrate-analogue inhibitors on nitric oxide synthase dimerization,” Biochemical and Biophysical Research Communications, vol. 418, no. 1, pp. 49–55, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. O. Santos, T. Ueda-Nakamura, B. P. D. Filho, V. F. V. Junior, A. C. Pinto, and C. V. Nakamura, “Effect of Brazilian copaiba oils on Leishmania amazonensis,” Journal of Ethnopharmacology, vol. 120, no. 2, pp. 204–208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. A. O. dos Santos, T. Ueda-Nakamura, B. P. D. Filho, V. F. D. V. Junior, and C. V. Nakamura, “Copaiba oil: an alternative to development of new drugs against leishmaniasis,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 898419, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. F. M. Balestieri, A. R. Queiroz, C. Scavone, V. M. Costa, M. Barral-Netto, and A. Abrahamsohn Ide, “Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages,” Microbes and Infection, vol. 4, no. 1, pp. 23–29, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Huang, F. W. Hoffmann, J. D. Fay et al., “Stimulation of unprimed macrophages with immune complexes triggers a low output of nitric oxide by calcium-dependent neuronal nitric-oxide synthase,” The Journal of Biological Chemistry, vol. 287, no. 7, pp. 4492–4502, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Connelly, A. T. Jacobs, M. Palacios-Callender, S. Moncada, and A. J. Hobbs, “Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression,” The Journal of Biological Chemistry, vol. 278, no. 29, pp. 26480–26487, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Nylen and S. Gautam, “Immunological perspectives of leishmaniasis,” Journal of Global Infectious Diseases, vol. 2, pp. 135–146, 2010. View at Google Scholar
  40. B. M. Babior, “Phagocytes and oxidative stress,” American Journal of Medicine, vol. 109, no. 1, pp. 33–44, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. A. C. Cunningham, “Parasitic adaptive mechanisms in infection by Leishmania,” Experimental and Molecular Pathology, vol. 72, no. 2, pp. 132–141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. F. L. van de Veerdonk, M. G. Netea, C. A. Dinarello, and L. A. B. Joosten, “Inflammasome activation and IL-1β and IL-18 processing during infection,” Trends in Immunology, vol. 32, no. 3, pp. 110–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. Ataide, W. A. Andrade, D. S. Zamboni et al., “Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection,” PLoS Pathogens, vol. 10, no. 1, Article ID e1003885, 2014. View at Publisher · View at Google Scholar · View at Scopus